TDR Capital seeks £2.5bn-plus sale of training business BPP June 30, 2024 British private equity giant TDR Capital is reportedly planning a £2.5bn-plus sale of professional training course business BPP.
Listed company TClarke behind Theatreland’s stage lights to go private April 17, 2024 TClarke, the London-headquartered firm which powered the world’s first electrically lit building - the Savoy Theatre - is to head into private hands.
London-listed Keywords Studios receives private equity bid at 73 per cent premium May 19, 2024 Video game services company Keywords Studios has said it would be "minded" to accept a £2.2bn takeover bid from Swedish private equity giant EQT Partners if it makes a firm offer.
Wood Group shares soar after engineering giant rejects takeover bid from Dubai-based rival May 8, 2024 It said the board concluded that the offer "fundamentally undervalued Wood and its future prospects" and rejected it earlier today.
DS Smith profit slips but boss hails £5.8bn takeover opportunity June 20, 2024 DS Smith said medium-term targets for box volume growth had been "significantly impacted" by inflation, in addition to lower production volumes.
K-Pop event firm’s shares remain suspended as losses continue to spiral February 6, 2024 Live Company, the firm behind children’s live entertainment group Bricklive and K-Pop Lux has published its 2022 financial accounts after a six month delay which resulted in it being suspended from the London Stock Exchange. Back in July, the Surrey based group was told it could no longer trade because it failed to publish its [...]
M&S pension scheme faces hefty losses as FCA probes Home REIT sister fund April 24, 2024 The M&S pension scheme is facing huge potential losses after pumping cash into a Home REIT sister fund that is now under investigation by the Financial Conduct Authority (FCA), City A.M. can reveal.
‘We are far from done’: Spectris CEO hails ‘excellent’ year as sales near £1.5bn February 29, 2024 Revenue neared £1.5bn at Spectris, the supplier of precision instrumentation and controls, during 2023 with its chief executive hailing the company's "excellent progress".
A bad trip: Oxford Cannabinoid to delist from ‘turbulent’ London markets May 8, 2024 Oxford Cannabinoid Technologies has given London markets further bad news after announcing plans to delist this morning.
Drugmaker Indivior seeks shareholder approval to move primary listing from London to New York April 25, 2024 Opioid dependence treatment maker Indivior has confirmed a plan to move its primary stock market listing from London to New York this summer in yet another blow to the capital's beleaguered bourse.